Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547869 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.
A NA study, sponsored by The University of Texas at Dallas.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03547869 is a NA study that was terminated before completion, run by The University of Texas at Dallas. The registered enrollment target is 9 participants.
The verdict
NCT03547869, a NA study, was terminated before completion, sponsored by The University of Texas at Dallas.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.
Interventions
- DEVICE Sham tDCS
- DEVICE Active tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2023-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03547869
The ClinicalTrials.gov registry entry for NCT03547869 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT03547869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03547869 about?
NCT03547869 is a clinical study titled "Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.". The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.
What is the current status of trial NCT03547869?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-03-12. Estimated completion is 2023-01-25.
What interventions are being tested in trial NCT03547869?
The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).
Who is sponsoring clinical trial NCT03547869?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.